New drug for COVID-19 treatment is developed in St. Louis with clinical trial in Kansas.

Kathleen Berger and Dr. Joe Monahan, PhD, discuss a clinical trial of ATI-450, a rheumatoid arthritis drug, as a possible treatment for COVID-19 infections.

Bibliographic Details

Other Authors:	Berger, Kathleen (Speaker), Monahan, Joe (practitioner.)
Format:	Video
Language:	English
Language Notes:	Closed-captioned in English.
Published:	[Place of publication not identified] : Educate.Today, 2020.
Subjects:	COVID-19 (Disease) > Treatment. Drugs > Testing. Clinical Trials as Topic COVID-19 > Traitement. Médicaments > Essais cliniques.
Online Access:	Connect to this streaming video